Department of Biochemistry and Biotechnology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
J Biol Chem. 2023 May;299(5):104656. doi: 10.1016/j.jbc.2023.104656. Epub 2023 Mar 27.
Proliferating cell nuclear antigen (PCNA) is a sliding clamp protein that coordinates DNA replication with various DNA maintenance events that are critical for human health. Recently, a hypomorphic homozygous serine to isoleucine (S228I) substitution in PCNA was described to underlie a rare DNA repair disorder known as PCNA-associated DNA repair disorder (PARD). PARD symptoms range from UV sensitivity, neurodegeneration, telangiectasia, and premature aging. We, and others, previously showed that the S228I variant changes the protein-binding pocket of PCNA to a conformation that impairs interactions with specific partners. Here, we report a second PCNA substitution (C148S) that also causes PARD. Unlike PCNA-S228I, PCNA-C148S has WT-like structure and affinity toward partners. In contrast, both disease-associated variants possess a thermostability defect. Furthermore, patient-derived cells homozygous for the C148S allele exhibit low levels of chromatin-bound PCNA and display temperature-dependent phenotypes. The stability defect of both PARD variants indicates that PCNA levels are likely an important driver of PARD disease. These results significantly advance our understanding of PARD and will likely stimulate additional work focused on clinical, diagnostic, and therapeutic aspects of this severe disease.
增殖细胞核抗原(PCNA)是一种滑动夹蛋白,它协调 DNA 复制与各种对人类健康至关重要的 DNA 维持事件。最近,PCNA 中一个低功能的纯合丝氨酸到异亮氨酸(S228I)取代被描述为一种罕见的 DNA 修复障碍的基础,称为 PCNA 相关的 DNA 修复障碍(PARD)。PARD 的症状范围从紫外线敏感、神经退行性变、毛细血管扩张和早衰。我们和其他人之前曾表明,S228I 变体改变了 PCNA 的蛋白结合口袋,使其构象受损,无法与特定的伙伴相互作用。在这里,我们报告了第二个也会导致 PARD 的 PCNA 取代(C148S)。与 PCNA-S228I 不同,PCNA-C148S 具有 WT 样结构和与伙伴的亲和力。相比之下,两种疾病相关变体都具有热稳定性缺陷。此外,携带 C148S 等位基因的纯合子患者细胞显示出低水平的染色质结合 PCNA,并表现出温度依赖性表型。两种 PARD 变体的稳定性缺陷表明,PCNA 水平可能是 PARD 疾病的一个重要驱动因素。这些结果大大提高了我们对 PARD 的理解,并可能会激发更多针对这种严重疾病的临床、诊断和治疗方面的工作。